🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a single-arm, prospective, multi-center clinical trial. desig...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2019-12-31
Trial ID
NCT04303130
Treatments Being Tested
This study is to evaluate the safety, tolerability, clinical efficacy and p...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2011-09
Trial ID
NCT01531790
Treatments Being Tested
To evaluate the effectiveness, safety and tolerability of Endostar (recombi...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2020-09-01
Trial ID
NCT04699214
Treatments Being Tested
To explore the efficacy and safety of immune checkpoint inhibitor combined ...
Status
Unknown
Location
Yancheng Clinical College of Xuzhou Medical University
Start Date
2023-06-01
Trial ID
NCT05782764
This is a Phase II clinical trial to evaluate the efficacy and safety of pe...
Status
Recruiting
Location
Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center
Start Date
2025-01-01
Trial ID
NCT06965231
Treatments Being Tested
Endostar is a anti-angiogenesis product and has been launched in China . Th...
Status
Unknown
Location
Tianjin Cancer Hospital
Start Date
2014-11
Trial ID
NCT02283476
A Study to Assess the Effects of Durvalumab following Rh-Endostatin combine...
Status
Unknown
Location
Multiple Locations
Start Date
2020-12-01
Trial ID
NCT04613284
Treatments Being Tested
Endostar is a anti-angiogenesis product and has been launched in China . Th...
Status
Unknown
Location
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Start Date
2018-10-01
Trial ID
NCT03706703
Treatments Being Tested
Endostar Continuous Intravenous Infusion Combined With Induction Chemothera...
Status
Unknown
Location
Multiple Locations
Start Date
2019-06
Trial ID
NCT03932266
Treatments Being Tested
This study is a prospective, exploratory Phase II clinical study aimed at e...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10-08
Trial ID
NCT06618391
Treatments Being Tested